Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

<< Previous

Bullboard Posts

Next >>

Post by Charly50on May 31, 2021 7:42am

250 Views

Post# 33295199

Sometimes Silence Is Gold.....

Talk is silver, silence is gold!

Suppose Sernova has good reasons to keep silence.

LONDON, ONTARIO - January 28, 2021 - Sernova Corp. (TSX-V: SVA)(OTCQB: SEOVF)(FWB: PSH), a leading clinical-stage regenerative medicine therapeutics company, today announced that it has entered into multiple research collaboration agreements with leading international pharmaceutical companies.

* Competitors do not sleep and are watching closely !

* They have to work hard and long until reliable results are available to

to be able to present them. The date is already set.

Still a little patience. As we know they have top people on board....

GLTA

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China